New drug cocktail shows promise for tough bile duct cancer
NCT ID NCT02386397
First seen Apr 01, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This study tested a combination of the targeted drug regorafenib and chemotherapy (mGEMOX) in 66 people with advanced biliary tract cancer that could not be removed by surgery. The goal was to find the safest dose and see if the combo helps control the cancer. The trial focused on side effects and tumor shrinkage, not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIGESTIVE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Val d'Aurelle
Montpellier, 34298, France
Conditions
Explore the condition pages connected to this study.